SAM
EW icon

Smithbridge Asset Management’s Edwards Lifesciences EW Stock Holding History

Smithbridge Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
16,854
+611
+4% +$51.2K 0.21% 89
2026
Q1 		$1.3M Sell
16,243
-16,155
-50% -$1.33M 0.19% 98
2025
Q4 		$2.76M Buy
32,398
+16,688
+106% +$1.37M 0.24% 72
2025
Q3 		$1.22M Buy
15,710
+455
+3% +$35.5K 0.18% 82
2025
Q2 		$1.19M Buy
15,255
+989
+7% +$73.8K 0.21% 72
2025
Q1 		$1.03M Buy
+14,266
New +$1.02M 0.19% 81
2024
Q3 		$864K Buy
13,086
+2,202
+20% +$160K 0.15% 103
2024
Q2 		$1.01M Sell
10,884
-167
-2% -$14.8K 0.21% 82
2024
Q1 		$1.06M Buy
11,051
+858
+8% +$72.1K 0.22% 83
2023
Q4 		$777K Buy
10,193
+411
+4% +$28.6K 0.18% 99
2023
Q3 		$678K Buy
9,782
+945
+11% +$75.9K 0.17% 104
2023
Q2 		$834K Buy
8,837
+437
+5% +$38K 0.2% 95
2023
Q1 		$695K Buy
8,400
+5,500
+190% +$432K 0.17% 101
2022
Q4 		$216K Sell
2,900
-7,700
-73% -$593K 0.06% 133
2022
Q3 		$876K Buy
10,600
+675
+7% +$65K 0.36% 67
2022
Q2 		$944K Hold
9,925
– – 0.36% 69
2022
Q1 		$1.17M Buy
9,925
+1,500
+18% +$168K 0.39% 67
2021
Q4 		$1.09M Buy
8,425
+250
+3% +$29.2K 0.33% 66
2021
Q3 		$925K Buy
8,175
+350
+4% +$40K 0.31% 70
2021
Q2 		$810K Buy
7,825
+300
+4% +$28.3K 0.26% 73
2021
Q1 		$629K Buy
7,525
+2,350
+45% +$199K 0.27% 60
2020
Q4 		$472K Buy
+5,175
New +$429K 0.22% 66

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Smithbridge Asset Management's EW Position: Q2 2026 in Review

Smithbridge Asset Management increased its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, buying an estimated $51.2K and bringing the position to 16,854 shares worth $1.52M. The position accounts for 0.21% of the portfolio, ranked #89.

Smithbridge Asset Management first reported a position in EW in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.76M in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Smithbridge Asset Management held 16,854 shares of Edwards Lifesciences worth $1.52M as of Q2 2026.
  • Smithbridge Asset Management bought 611 Edwards Lifesciences shares in Q2 2026, an estimated $51.2K.
  • Edwards Lifesciences made up 0.21% of Smithbridge Asset Management's portfolio in Q2 2026, its #89 holding.
  • Smithbridge Asset Management first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 22 quarters since.
  • Smithbridge Asset Management's Edwards Lifesciences position peaked at $2.76M in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.